by MM360 Staff | May 8, 2025 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | May 8, 2025 | Myeloma News
Source: Pharmacy Times articles Pharmacists can educate patients on non-pharmacologic strategies that help improve survival outcomes. Read More
by MM360 Staff | May 8, 2025 | Myeloma News
Source: Pharmacy Times articles These results build off prior studies which demonstrated effectiveness of Bergen 4-day treatment (B4DT) in patients with panic disorders. Read More
by MM360 Staff | May 8, 2025 | Myeloma News
Source: Pharmacy Times articles The Ensuring Community Access to Pharmacist Services (ECAPS) Act would enhance Medicare coverage for pharmacist services and ensure seniors can access essential care in underserved areas. Read More
by MM360 Staff | May 8, 2025 | Myeloma News
Source: Pharmacy Times articles The agent demonstrated promising tolerability and manageable safety. Read More
by MM360 Staff | May 8, 2025 | Myeloma News
Source: Pharmacy Times articles Trastuzumab deruxtecan was safe and efficacious prior to treatment with paclitaxel, trastuzumab, and pertuzumab. Read More